Annovis Bio, Inc. ( ANVS) - Stock Earnings
ANVS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.3 million USD | — USD |
| 2025Q4 | -9.8 million USD | — USD |
| 2026Q1 | -17.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ANVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -56.2 million USD | — USD |
| 2024 | -24.6 million USD | — USD |
| 2025 | -28.9 million USD | — USD |
| 2026 Est. | — | — |
ANVS
Price: $1.75
52 week price:
Earnings Per Share: -1.71 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 103127
Market Capitalization: 37.2 million